Please Wait
| Date | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $46,617.00 | -- | -- | -- | -- | -- | -- | -- | -- |
| Accounts Receivable Net Current | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $169,517.00 | $226,894.00 | $401,073.00 | $431,986.00 | -- | -- | -- | -- | -- |
| Property Plant and Equipement | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets Net | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Assets | $33,889,850.00 | $55,602,238.00 | $54,886,707.00 | $54,390,667.00 | $278,794.00 | -- | -- | $287,565.00 | -- |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accrued Liabilities | $719,385.00 | $612,550.00 | $560,005.00 | $124,599.00 | $65,000.00 | -- | -- | $65,000.00 | -- |
| Total Current Liabilities | $17,629,560.00 | $26,125,679.00 | $3,236,742.00 | $2,516,531.00 | -- | -- | -- | -- | -- |
| Long Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Other Comprehensive Loss | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Deficit | $-3,921,616.00 | $-3,399,350.00 | $-93,255.00 | $130,916.00 | $-11,206.00 | -- | -- | $-3,935.00 | -- |
| Total Stockholders' Equity | $-3,921,450.00 | $-3,399,184.00 | $1,018,991.00 | $5,045,303.00 | $13,794.00 | $8,780.00 | $13,747.00 | $21,065.00 | $21,365.00 |
| Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities and Equity | $33,889,850.00 | $55,602,238.00 | $54,886,707.00 | $54,390,667.00 | $278,794.00 | -- | -- | $287,565.00 | -- |
| Date | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research and Development | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss from Operations | $-1,356,343.00 | $-326,212.00 | $-679,020.00 | $-220,601.00 | -- | -- | -- | -- | -- |
| Loss Before Income Taxes | $304,894.00 | $216,861.00 | $-106,638.00 | $217,130.00 | -- | -- | -- | -- | -- |
| Earnings Per Share Basic | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Basic | -- | -- | -- | -- | 1,250,000 | -- | -- | -- | 1,250,000 |
| Earnings Per Share Diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Diluted | -- | -- | -- | -- | 1,250,000 | -- | -- | -- | 1,250,000 |
| Common Stock Shares Authorized | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | -- | -- | 16,000,000 | -- |
| Common Stock Shares Outstanding | 1,662,623 | 1,662,623 | 1,662,623 | 1,662,623 | 1,437,500 | -- | -- | 1,437,500 | -- |
| Common Stock Value | $166.00 | $166.00 | $166.00 | $166.00 | $144.00 | -- | -- | $144.00 | -- |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -- | -- | $0.00 | -- |
| Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Authorized | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Par Or Stated Value Per Share | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Share Price | -- | -- | -- | -- | -- | -- | -- | -- | -- |